These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Ipilimumab: from preclinical development to future clinical perspectives in melanoma. Letendre P; Monga V; Milhem M; Zakharia Y Future Oncol; 2017 Mar; 13(7):625-636. PubMed ID: 27882779 [TBL] [Abstract][Full Text] [Related]
14. Update on the role of ipilimumab in melanoma and first data on new combination therapies. Maio M; Di Giacomo AM; Robert C; Eggermont AM Curr Opin Oncol; 2013 Mar; 25(2):166-72. PubMed ID: 23299197 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms and strategies to overcome resistance to molecularly targeted therapy for melanoma. Lim SY; Menzies AM; Rizos H Cancer; 2017 Jun; 123(S11):2118-2129. PubMed ID: 28543695 [TBL] [Abstract][Full Text] [Related]
16. Trial watch: ipilimumab success in melanoma provides boost for cancer immunotherapy. Nat Rev Drug Discov; 2010 Aug; 9(8):584. PubMed ID: 20671754 [No Abstract] [Full Text] [Related]